Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.7K
DNA Damage can Stall the Cell Cycle02:37

DNA Damage can Stall the Cell Cycle

9.2K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Future Directions and Priorities for Cellular Therapy in Sarcoma: A Report from the Strategic Advances in Sarcoma Science Cell Therapy Breakout.

Cancers·2025
Same author

Phase II Trial of Ponatinib in Patients with Metastatic Gastrointestinal Stromal Tumor following Failure or Intolerance of Prior Therapy with Imatinib (POETIG Trial).

Clinical cancer research : an official journal of the American Association for Cancer Research·2025
Same author

Dedifferentiated Solitary Fibrous Tumor: A Clinicopathologic, Immunohistochemical, and Molecular Characterization of 25 Cases.

The American journal of surgical pathology·2025
Same author

Ferroptosis as a therapeutic vulnerability in MDM2 inhibition in dedifferentiated liposarcoma.

Oncology letters·2025
Same author

The activated tyrosine kinase ACK1 by multiple receptor tyrosine kinases promotes proliferation and invasion of mesothelioma via regulation of PI3K/AKT/mTOR and RAF/MAPK signaling pathways.

Cancer gene therapy·2025
Same author

Sarcoma of the Uterus. Guideline of the DGGG, OEGGG and SGGG (S2k-Level, AWMF Registry No. 015/074, June 2024).

Geburtshilfe und Frauenheilkunde·2025
Same journal

Clinical Trials and Translational Advances in Metabolic Targeting.

Cancer treatment and research·2026
Same journal

Tools and Technologies for Studying Cancer Metabolism.

Cancer treatment and research·2026
Same journal

Cancer and Immune Cells: A Metabolic Battle in the Tumor Microenvironment.

Cancer treatment and research·2026
Same journal

Biomarkers of Cancer Metabolism and Therapeutic Response.

Cancer treatment and research·2026
Same journal

Targeting Metabolism in Cancer Therapy: Inhibitors and Approaches.

Cancer treatment and research·2026
Same journal

Metabolic Reprogramming in Cancer Stem Cells.

Cancer treatment and research·2026
See all related articles

Related Experiment Video

Updated: Jul 10, 2025

Single Molecule Analysis of Laser Localized Psoralen Adducts
11:46

Single Molecule Analysis of Laser Localized Psoralen Adducts

Published on: April 20, 2017

6.7K

Targeting DNA-PK.

Jan Philipp Novotny1, Adrian Mariño-Enríquez2, Jonathan A Fletcher2

  • 1Department of Pathology, Brigham and Women's Hospital, Boston, USA. JanPhilipp.Novotny@med.uni-heidelberg.de.

Cancer Treatment and Research
|November 17, 2023
PubMed
Summary
This summary is machine-generated.

DNA-activated protein kinase (DNA-PK) is crucial for DNA repair and other processes. Understanding its complex roles offers new cancer treatment avenues but also presents challenges for combination therapies.

Keywords:
DNA damageDNA-PKImmunityNHEJTherapy

More Related Videos

Laser Microirradiation to Study In Vivo Cellular Responses to Simple and Complex DNA Damage
10:44

Laser Microirradiation to Study In Vivo Cellular Responses to Simple and Complex DNA Damage

Published on: January 31, 2018

10.3K
Investigation of Protein Recruitment to DNA Lesions Using 405 Nm Laser Micro-irradiation
12:29

Investigation of Protein Recruitment to DNA Lesions Using 405 Nm Laser Micro-irradiation

Published on: March 20, 2018

9.5K

Related Experiment Videos

Last Updated: Jul 10, 2025

Single Molecule Analysis of Laser Localized Psoralen Adducts
11:46

Single Molecule Analysis of Laser Localized Psoralen Adducts

Published on: April 20, 2017

6.7K
Laser Microirradiation to Study In Vivo Cellular Responses to Simple and Complex DNA Damage
10:44

Laser Microirradiation to Study In Vivo Cellular Responses to Simple and Complex DNA Damage

Published on: January 31, 2018

10.3K
Investigation of Protein Recruitment to DNA Lesions Using 405 Nm Laser Micro-irradiation
12:29

Investigation of Protein Recruitment to DNA Lesions Using 405 Nm Laser Micro-irradiation

Published on: March 20, 2018

9.5K

Area of Science:

  • Molecular Biology
  • Genetics
  • Cancer Research

Background:

  • DNA-activated protein kinase (DNA-PK) is a key regulator of DNA repair pathways.
  • Non-homologous end-joining (NHEJ) is a major DNA double-strand break repair mechanism orchestrated by DNA-PK.
  • Emerging evidence indicates DNA-PK's involvement in diverse biological processes beyond DNA repair.

Purpose of the Study:

  • To explore the multifaceted roles of DNA-PK.
  • To focus on DNA-PK's function in non-homologous end-joining (NHEJ) DNA repair.
  • To discuss the implications of DNA-PK's varied roles for cancer therapeutics.

Main Methods:

  • Literature review and synthesis of current research on DNA-PK.
  • Analysis of DNA-PK's involvement in NHEJ and other cellular functions.
  • Discussion of clinical translation challenges and opportunities.

Main Results:

  • DNA-PK is confirmed as the central orchestrator of NHEJ.
  • DNA-PK regulates multiple biological processes beyond its canonical role in DNA repair.
  • The diverse functions of DNA-PK present both opportunities for novel cancer treatments and potential challenges for combination therapies.

Conclusions:

  • The complex biological roles of DNA-PK offer promising new avenues for cancer treatment strategies.
  • Challenges in clinical translation, including potential toxicities, necessitate innovative therapeutic approaches.
  • Further research is required to effectively harness DNA-PK's therapeutic potential while mitigating risks.